Back to User profile » Dr Jie Lu
Papers published by Dr Jie Lu:
Efficacy of Different Pancreatic Interventional Treatments for Chronic Calcific Pancreatitis: A Two-Year Multicenter Retrospective Study
Bao W, Wu D, Han W, Kong R, Wang N, Lu J
International Journal of General Medicine 2022, 15:7511-7521
Published Date: 25 September 2022
Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
Li S, Xia Y, Chen K, Li J, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2016, 10:631-647
Published Date: 15 February 2016
Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy
Li J, Chen K, Li S, Feng J, Liu T, Wang F, Zhang R, Xu S, Zhou Y, Zhou S, Xia Y, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2016, 10:619-630
Published Date: 12 February 2016
Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis
Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C
OncoTargets and Therapy 2015, 8:3585-3593
Published Date: 1 December 2015
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2015, 9:5947-5948
Published Date: 9 November 2015
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2015, 9:5407-5419
Published Date: 30 September 2015
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
Zhang Y, Li S, He L, Wang F, Chen K, Li J, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Xia Y, Zhou Y, Lu J, Guo C
Drug Design, Development and Therapy 2015, 9:2757-2766
Published Date: 25 May 2015
Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
Zhang H, Yang J, Zhu R, Zheng Y, Zhou Y, Dai W, Wang F, Chen K, Li J, Wang C, Li S, Liu T, Abudumijiti H, Zhou Z, Wang J, Lu W, Wang J, Xia Y, Zhou Y, Lu J, Guo C
Drug Design, Development and Therapy 2015, 9:567-574
Published Date: 17 January 2015
Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis
Cheng P, Chen K, Xia Y, Dai WQ, Wang F, Shen M, Wang C, Yang J, Zhu R, Zhang H, Li JJ, Zheng Y, Wang J, Zhang Y, Lu J, Zhou YQ, Guo CY
Drug Design, Development and Therapy 2014, 8:1277-1286
Published Date: 9 September 2014